Literature DB >> 23419491

Prostate cancer: improving PSA testing by adjusting for genetic background.

Peter T Scardino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23419491     DOI： 10.1038/nrurol.2013.28

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

Review 1.  Meta-analysis of genome-wide and replication association studies on prostate cancer.

Authors:  Hong Liu; Bo Wang; Chunsheng Han
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

2.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

3.  Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.

Authors:  Gianluca Severi; Vanessa M Hayes; Petra Neufing; Emma J D Padilla; Wayne D Tilley; Sarah A Eggleton; Howard A Morris; Dallas R English; Melissa C Southey; John L Hopper; Robert L Sutherland; Peter Boyle; Graham G Giles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

4.  Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.

Authors:  Andrew Vickers; Angel Cronin; Monique Roobol; Caroline Savage; Mari Peltola; Kim Pettersson; Peter T Scardino; Fritz Schröder; Hans Lilja
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

5.  Genetic correction of PSA values using sequence variants associated with PSA levels.

Authors:  Julius Gudmundsson; Soren Besenbacher; Patrick Sulem; Daniel F Gudbjartsson; Isleifur Olafsson; Sturla Arinbjarnarson; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Helgi J Isaksson; Jelena P Kostic; Sigurjon A Gudjonsson; Simon N Stacey; Arnaldur Gylfason; Asgeir Sigurdsson; Hilma Holm; Unnur S Bjornsdottir; Gudmundur I Eyjolfsson; Sebastian Navarrete; Fernando Fuertes; Maria D Garcia-Prats; Eduardo Polo; Ionel A Checherita; Mariana Jinga; Paula Badea; Katja K Aben; Jack A Schalken; Inge M van Oort; Fred C Sweep; Brian T Helfand; Michael Davis; Jenny L Donovan; Freddie C Hamdy; Kristleifur Kristjansson; Jeffrey R Gulcher; Gisli Masson; Augustine Kong; William J Catalona; Jose I Mayordomo; Gudmundur Geirsson; Gudmundur V Einarsson; Rosa B Barkardottir; Eirikur Jonsson; Viorel Jinga; Dana Mates; Lambertus A Kiemeney; David E Neal; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Sci Transl Med       Date:  2010-12-15       Impact factor: 17.956

6.  Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.

Authors:  Markus Aly; Fredrik Wiklund; Jianfeng Xu; William B Isaacs; Martin Eklund; Mauro D'Amato; Jan Adolfsson; Henrik Grönberg
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

7.  Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies.

Authors:  Brian T Helfand; Stacy Loeb; Qiaoyan Hu; Phillip R Cooper; Kimberly A Roehl; Barry B McGuire; Nikola A Baumann; William J Catalona
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

8.  Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.

Authors:  Stacy Loeb; Lori J Sokoll; Dennis L Broyles; Chris H Bangma; Ron H N van Schaik; George G Klee; John T Wei; Martin G Sanda; Alan W Partin; Kevin M Slawin; Leonard S Marks; Isaac A Mizrahi; Sanghyuk S Shin; Amabelle B Cruz; Daniel W Chan; William L Roberts; William J Catalona
Journal:  J Urol       Date:  2012-11-30       Impact factor: 7.450

9.  Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.

Authors:  Stacy Loeb; H Ballentine Carter; Patrick C Walsh; William B Isaacs; Anna Kettermann; Toshiko Tanaka; Luigi Ferrucci; E Jeffrey Metter
Journal:  J Urol       Date:  2009-05-17       Impact factor: 7.450

10.  Multiple newly identified loci associated with prostate cancer susceptibility.

Authors:  Rosalind A Eeles; Zsofia Kote-Jarai; Graham G Giles; Ali Amin Al Olama; Michelle Guy; Sarah K Jugurnauth; Shani Mulholland; Daniel A Leongamornlert; Stephen M Edwards; Jonathan Morrison; Helen I Field; Melissa C Southey; Gianluca Severi; Jenny L Donovan; Freddie C Hamdy; David P Dearnaley; Kenneth R Muir; Charmaine Smith; Melisa Bagnato; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Beatrice N Gehr-Swain; Rosemary A Wilkinson; Angie Cox; Sarah Lewis; Paul M Brown; Sameer G Jhavar; Malgorzata Tymrakiewicz; Artitaya Lophatananon; Sarah L Bryant; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Cyril Fisher; Charles Jamieson; Colin S Cooper; Dallas R English; John L Hopper; David E Neal; Douglas F Easton
Journal:  Nat Genet       Date:  2008-02-10       Impact factor: 38.330
  10 in total
  2 in total

Review 1.  A genetic-based approach to personalized prostate cancer screening and treatment.

Authors:  Brian T Helfand; William J Catalona; Jianfeng Xu
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

Review 2.  Multigene panels in prostate cancer risk assessment: a systematic review.

Authors:  Julian Little; Brenda Wilson; Ron Carter; Kate Walker; Pasqualina Santaguida; Eva Tomiak; Joseph Beyene; Muhammad Usman Ali; Parminder Raina
Journal:  Genet Med       Date:  2015-10-01       Impact factor: 8.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.